Meinhardt G, Hass R
Division of Cancer Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School Boston, MA 02115, USA.
Leuk Res. 1995 Oct;19(10):699-705. doi: 10.1016/0145-2126(95)00040-u.
Previous studies in human myeloid leukemia cells (HL-60, U-937, THP-1) suggested an involvement of the c-myc gene in the control of mutually exclusive pathways, such as retrodifferentiation and cell death. Treatment of U-937 cells with 12-O-tetradecanoyl phorbol-13-acetate (TPA) which is associated with the induction of a monocytic differentiation program and growth arrest, revealed an initial up-regulation of c-myc, c-max, and mxi1 mRNAs after 1-6 h. Thereafter expression of these genes significantly declined to barely detectable levels when the cells ceased to grow after 12-24 h of TPA treatment. Between 7 and 11 days of TPA-induced G0/G1 cell cycle arrest, expression of the c-max and mxi1 genes continuously increased up to 8-fold until 32 days and declined to control levels when the cells regained proliferative capacity by 36 days. In contrast, c-myc mRNAs remained down-regulated during periods of growth arrest and increased only during re-entry into the cell cycle after 36 days. This effect is consistent with a retrodifferentiation process, whereby previously differentiated cells revert back to the undifferentiated phenotype and re-enter the cell cycle. Different results were obtained during serum starvation-induced cell death of U-937 cells. After 48-72 h of serum-starvation, expression of the c-myc and c-max genes were significantly down-regulated by 4-fold and 3-fold, respectively, while there was little, if any, change in mxi1 mRNA levels. Analysis of cell death in serum-starved U-937 cells demonstrated progressively increasing DNA fragmentation reaching 45.4% +/- 0.9% after 72 h. Synchronization of proliferating U-937 cells throughout distinct phases of the cell cycle exhibited little, if any, change in c-myc, c-max and mxi1 mRNAs. Furthermore, like c-myc, c-max and mxi1 mRNA transcripts appeared to be regulated primarily by post-transcriptional mechanisms, and c-max and mxi1 half-lives exceeded 4 h in contrast to < 60 min for the c-myc gene. Taken together, these findings suggested differential regulation and inverse expression levels of c-myc compared to c-max and mxi1 during differentiation, retrodifferentiation and cell death.
先前针对人类髓系白血病细胞(HL-60、U-937、THP-1)的研究表明,c-myc基因参与了相互排斥的信号通路调控,如逆向分化和细胞死亡。用12-O-十四烷酰佛波醇-13-乙酸酯(TPA)处理U-937细胞,该处理与单核细胞分化程序的诱导和生长停滞相关,结果显示在1-6小时后c-myc、c-max和mxi1 mRNA出现初始上调。此后,当TPA处理12-24小时后细胞停止生长时,这些基因的表达显著下降至几乎检测不到的水平。在TPA诱导的G0/G1细胞周期停滞的7至11天期间,c-max和mxi1基因的表达持续增加,直至32天增加至8倍,当细胞在36天恢复增殖能力时下降至对照水平。相反,c-myc mRNA在生长停滞期间仍处于下调状态,仅在36天后重新进入细胞周期时增加。这种效应与逆向分化过程一致,即先前分化的细胞恢复到未分化表型并重新进入细胞周期。在血清饥饿诱导的U-937细胞死亡过程中获得了不同的结果。血清饥饿48-72小时后,c-myc和c-max基因的表达分别显著下调4倍和3倍而mxi1 mRNA水平几乎没有变化。对血清饥饿的U-937细胞中的细胞死亡分析表明,DNA片段化逐渐增加,72小时后达到45.4%±0.9%。使增殖的U-937细胞在细胞周期的不同阶段同步化,c-myc、c-max和mxi1 mRNA几乎没有变化。此外,与c-myc一样,c-max和mxi1 mRNA转录本似乎主要受转录后机制调控,c-max和mxi1的半衰期超过4小时,而c-myc基因的半衰期小于60分钟。综上所述,这些发现表明在分化、逆向分化和细胞死亡过程中,c-myc与c-max和mxi1相比存在差异调控和相反的表达水平。